Catalyst Wire Dossier Catalyst Wire Dossier

Bioconjugate vaccine against Shigella flexneri 2a

· LimmaTech Biologics AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bioconjugate vaccine against Shigella flexneri 2a, covering 2015-12-22 to 2015-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a [Phase 1]

See pricing